Meeting Program

Monday, February 3, 2014                             
Session 1:  Coronary
Chronic Stable Angina-QOL vs. MACE Reduction Benefit with Intervention
    Speaker:      Peter Wijngaard
    Moderator:   Steve Bailey
    Panelists:     Larry Dean, George Hanzel, Tarek Helmy, Bonnie Weiner

Session 1:  Coronary
Coronary Lesion Assessment:  Are FFR and iFR it?
    Speaker:      Tarek Helmy
    Moderator:   Steve Bailey
    Panelists:     Larry Dean, George Hanzel, Bonnie Weiner, Peter Wijngaard

Session 1:  Coronary
Can OCT Identify ACS Patients Who Don't Need Stents?
    Speaker:      George Hanzel
    Moderator:   Steve Bailey
    Panelists:     Larry Dean, Tarek Helmy, Bonnie Weiner, Peter Wijngaard

Session 2:  Structural
Is Perivalvular Leak the Achilles Heel of TAVR and How to Obtain Best Outcomes
    Speaker:      Larry Dean
    Moderator:   Jim Zidar
    Panelists:      Steve Bailey, Robert Bersin, Bill O’Neill

Session 2:  Structural
Valves and Other Devices for Structural Mitral Valve Disease
    Speaker:      Bill O’Neill
    Moderator:   Jim Zidar
    Panelists:     Steve Bailey, Robert Bersin, Larry Dean

Session 2:  Structural
Devices for Functional MR: One Clip, Two Clip, Three Clip, Four?
    Speaker:      Steve Bailey
    Moderator:   Jim Zidar
    Panelists:     Robert Bersin, Larry Dean, Bill O’Neill

Session 3:  Endovascular
Aortic Frontiers: The Prophylactic Treatment of Uncomplicated Type B Dissection
    Speaker:      Robert Bersin
    Moderator:   Tyrone Collins
    Panelists:     Dieter Liermann, Klaus Mathias, Sigrid Nikol, Souheil Saddekni, Jiri Vitek, Jim Zidar

Session 3:  Endovascular
Endovascular Drug Eluting Balloons vs. Stents:  Is Provisional Stenting Back?
    Speaker:      Jim Zidar
    Moderator:   Tyrone Collins
    Panelists:     Robert Bersin, Dieter Liermann, Klaus Mathias, Sigrid Nikol,  Souheil Saddekni, Jiri Vitek

Session 3:  Endovascular
What to do with the Asymptomatic Carotid Stenosis?
    Speaker:      Klaus Mathias
    Moderator:   Tyrone Collins
    Panelists:     Robert Bersin, Dieter Liermann, Sigrid Nikol, Souheil Saddekni, Jiri Vitek, Jim Zidar

Tuesday, February 4, 2014                             
Session 4:  Emerging Therapies
Destination Therapy for Heart Failure: What to do When the Batteries Run Out?
    Speaker:      Michael Mooney
    Moderator:   Nickolas Kipshidze
    Panelists:     George Hanzel, David Kallend, Bill O’Neill, Peter Wijngaard

Session 4:  Emerging Therapies
Myocyte Recovery Strategies and Cell Therapies for Myocardial Regeneration Post MI
    Speaker:     Bill O’Neill
    Moderator:  Nickolas Kipshidze
    Panelists:    George Hanzel, David Kallend, Michael Mooney, Peter Wijngaard

Session 4:  Emerging Therapies
Novel Therapies for Plaque Inflammation
    Speaker:     David Kallend
    Moderator:  Nickolas Kipshidze
    Panelists:    George Hanzel, Michael Mooney, Bill O’Neill, Peter Wijngaard

Session 5:  Coronary
CTOs: Should the Appropriateness Criteria Change in an Era of Better Outcomes?
    Speaker:     Bonnie Weiner
    Moderator:  Peter Wijngaard
    Panelists:    Evelyn Baram-Clothier, Tyrone Collins, Larry Dean, Kirk Garratt, Adam Greenbaum, Tarek Helmy, Michael Mooney

Session 5:  Coronary
Transradial Access for STEMI: Is the ESC Consensus Recommendation Warranted by the Evidence?
    Speaker:      Kirk Garratt
    Moderator:  Peter Wijngaard
    Panelists:    Evelyn Baram-Clothier, Tyrone Collins, Larry Dean, Adam Greenbaum, Tarek Helmy, Michael Mooney, Bonnie Weiner

Session 5:  Coronary
Outpatient Intervention: Good or Bad Dream?
    Speaker:      Adam Greenbaum
    Moderator:  Peter Wijngaard
    Panelists:    Evelyn Baram-Clothier, Tyrone Collins, Larry Dean, Kirk Garratt, Tarek Helmy, Michael Mooney, Bonnie Weiner


Session 6:  Structural
PFO: Should Anyone be Closed and With What?
    Speaker:      Kirk Garratt
    Moderator:  Steve Bailey
    Panelists:    Gyula Gal, Adam Greenbaum, Nickolas Kipshidze, Brian O’Murchu

Session 6:  Structural
NEW TOPIC:  Penumbra Direct Aspiration System:  Removing Clots for Acute Ischemic Stroke
    Speaker:     Gyula Gal
    Moderator:  Steve Bailey
    Panelists:    Kirk Garratt, Adam Greenbaum, Nickolas Kipshidze, Brian O’Murchu

Session 6:  Structural
Hybrid Imaging: Synergy and Co-registration of X-ray, CT and 3D Echo in the Interventional Suite
    Speaker:      Brian O’Murchu    
    Moderator:   Steve Bailey    
    Panelists:     Gyula Gal, Kirk Garratt, Adam Greenbaum, Nickolas Kipshidze

Wednesday, February 5, 2014                         
Session 7:  Endovascular
Mechanical Devices for Acute Stroke Intervention: Why Did the Trials Fail?
    Speaker:     Tyrone Collins
    Moderator:  Dieter Liermann
    Panelists:    Robert Bersin, Gyula Gal, Klaus Mathias, Sigrid Nikol, Souheil Saddekni, Jiri Vitek

Session 7:  Endovascular
DVT/PE:  Why are Interventional Therapies so Far Behind the Times?
    Speaker:     Jiri Vitek
    Moderator:  Dieter Liermann
    Panelists:    Robert Bersin, Tyrone Collins, Gyula Gal, Klaus Mathias, Sigrid Nikol, Souheil Saddekni

Session 7:  Endovascular
Novel Lower Extremity Interventions: Chocolate TOBA, or Something Like That?
    Speaker:     Sigrid Nikol
    Moderator:  Dieter Liermann
    Panelists:    Robert Bersin, Tyrone Collins, Gyula Gal, Klaus Mathias, Souheil Saddekni, Jiri Vitek

Session 8:  Medical Therapies
HDL Raising: Raising the Dead?
    Speaker:     Dennis Goodman
    Moderator:  Bonnie Weiner
    Panelists:    Kirk Garratt, Richard Shaw, Peter Wijngaard

Session 8:  Medical Therapies
CANCELLED - RNA Interference Therapies, Micro-RNA and Epigenetics
    Speaker:     Tim Henry
    Moderator:  Bonnie Weiner
    Panelists:    Kirk Garratt, Dennis Goodman, Richard Shaw, Peter Wijngaard

Session 8:  Medical Therapies
Gene Mapping and Targeted Medical Therapies: The Next iPhone App?
    Speaker:     Richard Shaw  
    Moderator:  Bonnie Weiner
    Panelists:    Kirk Garratt, Dennis Goodman, Peter Wijngaard

Session 9:  Emerging Therapies
Renal Denervation: Is a BP Endpoint Sufficient or is a Reduction in MACE Necessary for Adoption and Reimbursement?
    Speaker:      Jeff Marshall
    Moderator:  Dennis Goodman
    Panelists:    Dieter Liermann, Klaus Mathias, B. O’Murchu, Souheil Saddekni, R. Shaw, Jim Zidar

Session 9:  Emerging Therapies
Other Denervation Therapies:  Hype or Substance?
    Speaker:     Klaus Mathias
    Moderator:  Dennis Goodman
    Panelists:    Dieter Liermann, Jeff Marshall, Brian O’Murchu, Souheil Saddekni, Richard Shaw, Jim Zidar

Session 9:  Emerging Therapies
Devices for Diastolic Dysfunction:  The Golden Parachute?
    Speaker:     Brian O’Murchu
    Moderator:  Dennis Goodman
    Panelists:    Dieter Liermann, Jeff Marshall, Klaus Mathias, Souheil Saddekni, R Shaw, Jim Zidar

Thursday, February 6, 2014                          
Session 10:  Coronary
Is Intervention Dead in Diabetics with Multivessel Disease?
    Speaker:      Adam Greenbaum
    Moderator:   Michael Mooney
    Panelists:    George Hanzel, Tarek Helmy, Nickolas Kipshidze, Bill O’Neill, Richard Shaw

Session 10:  Coronary
Bioresorbable Stents and Drug Eluting Balloons:  How Do We Best Get the Drug There?
    Speaker:      Nickolas Kipshidze
    Moderator:   Michael Mooney
    Panelists:     Adam Greenbaum, George Hanzel, Tarek Helmy, Bill O’Neill, Richard Shaw

Session 10:  Coronary
Best Approaches to Hemodynamic Support for Cardiogenic Shock and High Risk PCI
    Speaker:     Bill O’Neill
    Moderator:  Michael Mooney
    Panelists:    Adam Greenbaum, George Hanzel, Tarek Helmy, Nickolas Kipshidze, Richard Shaw

Session 11:  Industry
How to Approach the Increasing Worldwide Disconnect Between Evidence, Indication and Reimbursement
    Speaker:      Roundtable Discussion
    Moderator:   Jeff Marshall
    Panelists:     Sam Conaway, Matt Franklin, Lillian Garcia Palmer, Melissa Gindling, Paul Goodman, David Kallend, Richard Shaw,                Jason Struck, Mike Vonesh

Session 11:  Industry
Cost Effectiveness Research: Sorely Needed for Interventional Therapies
    Speaker:      Roundtable Discussion
    Moderator:   Jeff Marshall
    Panelists:     Sam Conaway, Matt Franklin, Lillian Garcia Palmer, Melissa Gindling, Paul Goodman, David Kallend, Richard Shaw, Jason Struck, Mike Vonesh

Session 11:  Industry
ACOs:  Industry's Role in Bringing Providers and Payors Together
    Speaker:      Roundtable Discussion
    Moderator:   Jeff Marshall
    Panelists:     Sam Conaway, Matt Franklin, Lillian Garcia Palmer, Melissa Gindling, Paul Goodman, David Kallend, Richard Shaw, Jason Struck, Mike Vonesh

Session 12: IAGS Business Meeting